- Home
- Publications
- Publication Search
- Publication Details
Title
Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 8, Pages 2793
Publisher
MDPI AG
Online
2020-04-21
DOI
10.3390/ijms21082793
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy
- (2020) Zihua Zeng et al. Cancers
- Targeted delivery of Rab26 siRNA with precisely tailored DNA prism for lung cancer therapy
- (2019) Qian Liu et al. CHEMBIOCHEM
- A Combined ELONA-(RT)qPCR Approach for Characterizing DNA and RNA Aptamers Selected against PCBP-2
- (2019) Miguel Moreno et al. MOLECULES
- DNA Nanoscaffold‐Assisted Selection of Femtomolar Bivalent Aptamers for Human α‐Thrombin with Potent Anticoagulant Activity
- (2019) Yu Zhou et al. CHEMBIOCHEM
- Updates on Aptamer Research
- (2019) Ali et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?
- (2019) S. K. Haßel et al. Molecular Diagnosis & Therapy
- Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells
- (2019) Tayebeh Saleh et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- ICOS costimulation at the tumor site in combination with CTLA-4 blockade therapy elicits strong tumor immunity
- (2019) Mario Martínez Soldevilla et al. MOLECULAR THERAPY
- Elimination of HER3‑expressing breast cancer cells using aptamer‑siRNA chimeras
- (2019) Inga Nachreiner et al. Experimental and Therapeutic Medicine
- HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation
- (2019) Tao Duan et al. BIOMEDICINE & PHARMACOTHERAPY
- Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
- (2019) Fadwa Odeh et al. MOLECULES
- Nucleic Acid Aptamer: A Novel Potential Diagnostic and Therapeutic Tool for Leukemia
- (2019) Yuan Tan et al. OncoTargets and Therapy
- Aptamer chemistry
- (2018) Pascal Röthlisberger et al. ADVANCED DRUG DELIVERY REVIEWS
- Aptamers: Uptake mechanisms and intracellular applications
- (2018) Sorah Yoon et al. ADVANCED DRUG DELIVERY REVIEWS
- Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications
- (2018) Simona Camorani et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Challenging cancer targets for aptamer delivery
- (2018) Vittorio de Franciscis BIOCHIMIE
- Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer
- (2018) Meng Wu et al. DRUG DELIVERY
- Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model
- (2018) Walhan Alshaer et al. JOURNAL OF CONTROLLED RELEASE
- The PDGF/PDGFR pathway as a drug target
- (2018) Natalia Papadopoulos et al. MOLECULAR ASPECTS OF MEDICINE
- Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents
- (2018) Minhee Kim et al. MOLECULES
- Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo
- (2018) Matthew R Hassler et al. NUCLEIC ACIDS RESEARCH
- Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1
- (2018) Jiehua Zhou et al. Theranostics
- STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
- (2018) Carla Lucia Esposito et al. Molecular Therapy-Nucleic Acids
- Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2 + Breast Cancer
- (2018) Xiaolin Yu et al. Molecular Therapy-Nucleic Acids
- Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers
- (2018) Christina Kratschmer et al. Molecular Therapy-Nucleic Acids
- Potentiating tumor immunity using aptamer-targeted RNAi to render CD8+ T cells resistant to TGFβ inhibition
- (2018) Yvonne Puplampu-Dove et al. OncoImmunology
- Aptamer Therapeutics in Cancer: Current and Future
- (2018) Yoshihiro Morita et al. Cancers
- Extended Duration Vascular Endothelial Growth Factor Inhibition in the Eye: Failures, Successes, and Future Possibilities
- (2018) Michael Stewart Pharmaceutics
- Cascaded Aptamers-Governed Multistage Drug-Delivery System Based on Biodegradable Envelope-Type Nanovehicle for Targeted Therapy of HER2-Overexpressing Breast Cancer
- (2018) Tingxizi Liang et al. ACS Applied Materials & Interfaces
- Aptamer-based targeted therapy
- (2018) Guizhi Zhu et al. ADVANCED DRUG DELIVERY REVIEWS
- Aptamer-guided nanomedicines for anticancer drug delivery
- (2018) Walhan Alshaer et al. ADVANCED DRUG DELIVERY REVIEWS
- SELEX methods on the road to protein targeting with nucleic acid aptamers
- (2018) Payam Bayat et al. BIOCHIMIE
- Synergistic targeting HER2 and EGFR with a bivalent aptamer-siRNA chimera efficiently inhibits HER2-positive tumor growth
- (2018) LU XUE et al. MOLECULAR PHARMACEUTICS
- An RNA toolbox for cancer immunotherapy
- (2018) Fernando Pastor et al. NATURE REVIEWS DRUG DISCOVERY
- Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development
- (2018) Tao Wang et al. BIOTECHNOLOGY ADVANCES
- Pathological roles of the homeostatic chemokine CXCL12
- (2018) Rik Janssens et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Imaging whole nervous systems: insights into behavior from worms to fish
- (2018) John A. Calarco et al. NATURE METHODS
- Rational truncation of aptamer for cross-species application to detect krait envenomation
- (2018) Abhijeet Dhiman et al. Scientific Reports
- Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
- (2017) Shuaijian Ni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-co-glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer
- (2017) Meng Wu et al. International Journal of Nanomedicine
- Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer
- (2017) Carlos E.B. de Almeida et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A TIM-3 Oligonucleotide Aptamer Enhances T Cell Functions and Potentiates Tumor Immunity in Mice
- (2017) Tal Gefen et al. MOLECULAR THERAPY
- Aptamer-Targeted Attenuation of IL-2 Signaling in CD8 + T Cells Enhances Antitumor Immunity
- (2017) Anugraha Rajagopalan et al. MOLECULAR THERAPY
- Effect of Chemical Modifications on Aptamer Stability in Serum
- (2017) Christina Kratschmer et al. Nucleic Acid Therapeutics
- Pharmacokinetic Properties of DNA Aptamers with Base Modifications
- (2017) Shashi Gupta et al. Nucleic Acid Therapeutics
- Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
- (2017) Simona Camorani et al. Theranostics
- Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade
- (2017) Dirk Zboralski et al. Cancer Immunology Research
- Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside
- (2017) Byung-Sik Cho et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Systematic Optimization and Modification of a DNA Aptamer with 2’-O-Methyl RNA Analogues
- (2017) George E. Maio et al. ChemistrySelect
- Selection, Characterization and Application of Artificial DNA Aptamer Containing Appended Bases with Sub-nanomolar Affinity for a Salivary Biomarker
- (2017) Hirotaka Minagawa et al. Scientific Reports
- Targeting Platelet-Derived Growth Factor Receptor β + Scaffold Formation Inhibits Choroidal Neovascularization
- (2016) Karin Strittmatter et al. AMERICAN JOURNAL OF PATHOLOGY
- A specific aptamer-cell penetrating peptides complex delivered siRNA efficiently and suppressed prostate tumor growthin vivo
- (2016) Yanjun Diao et al. CANCER BIOLOGY & THERAPY
- Aptamers: The “evolution” of SELEX
- (2016) Yi Xi Wu et al. METHODS
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Advances in the development of aptamer drug conjugates for targeted drug delivery
- (2016) Ke Chen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects
- (2016) Wei-Yun Lai et al. Molecular Therapy-Nucleic Acids
- AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin
- (2016) Ye Cheng et al. PLoS One
- Targeting Tumor Vasculature with Aptamer-Functionalized Doxorubicin–Polylactide Nanoconjugates for Enhanced Cancer Therapy
- (2015) Li Tang et al. ACS Nano
- Specific aptamer-conjugated mesoporous silica–carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy
- (2015) Kaiyuan Wang et al. Acta Biomaterialia
- 2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasia
- (2015) Mario Martinez Soldevilla et al. BIOMATERIALS
- Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia
- (2015) Nianxi Zhao et al. BIOMATERIALS
- Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics
- (2015) Axel Vater et al. DRUG DISCOVERY TODAY
- Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells
- (2015) A. Gilboa-Geffen et al. MOLECULAR CANCER THERAPEUTICS
- Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2
- (2015) Dominik Oberthür et al. Nature Communications
- Identification of TIM3 2’-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy
- (2015) Sandra Hervas-Stubbs et al. Oncotarget
- Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
- (2015) Aaron Prodeus et al. Molecular Therapy-Nucleic Acids
- Reducing toxicity of 4–1BB costimulation: targeting 4–1BB ligands to the tumor stroma with bi-specific aptamer conjugates
- (2015) B Schrand et al. OncoImmunology
- Identification and Characterization of an Agonistic Aptamer Against the T Cell Costimulatory Receptor, OX40
- (2015) Elizabeth D. Pratico et al. Nucleic Acid Therapeutics
- NOX-A12: mobilizing CLL away from home
- (2014) R. Marasca et al. BLOOD
- 5-Hydroxymethyl-2′-Deoxyuridine Residues in the Thrombin Binding Aptamer: Investigating Anticoagulant Activity by Making a Tiny Chemical Modification
- (2014) Antonella Virgilio et al. CHEMBIOCHEM
- Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagenin vitroandin vivo
- (2014) Zhao Hao et al. DRUG DELIVERY
- Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRβ Aptamer
- (2014) Simona Camorani et al. MOLECULAR THERAPY
- Targeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane Antigen
- (2014) Justin P Dassie et al. MOLECULAR THERAPY
- Aptamers as Both Drugs and Drug-Carriers
- (2014) Md. Ashrafuzzaman Biomed Research International
- Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
- (2014) B. Schrand et al. Cancer Immunology Research
- Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
- (2014) A. C. Anderson Cancer Immunology Research
- A clinically useful approach to enhance immunological memory and antitumor immunity
- (2014) Alex Berezhnoy et al. OncoImmunology
- The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
- (2013) J. Hoellenriegel et al. BLOOD
- Use of Oligonucleotide Aptamer Ligands to Modulate the Function of Immune Receptors
- (2013) E. Gilboa et al. CLINICAL CANCER RESEARCH
- Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles
- (2013) Katarzyna Pala et al. International Journal of Nanomedicine
- Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
- (2013) Alexey Berezhnoy et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer
- (2013) Seyed Mohammad Taghdisi et al. JOURNAL OF DRUG TARGETING
- Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells
- (2013) Jiehua Zhou et al. NUCLEIC ACIDS RESEARCH
- An Ultra pH-Sensitive and Aptamer-Equipped Nanoscale Drug-Delivery System for Selective Killing of Tumor Cells
- (2013) Nianxi Zhao et al. Small
- CD28 Aptamers as Powerful Immune Response Modulators
- (2013) Fernando Pastor et al. Molecular Therapy-Nucleic Acids
- Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
- (2012) Zhe Liu et al. Journal of Translational Medicine
- Functional In Vivo Delivery of Multiplexed Anti-HIV-1 siRNAs via a Chemically Synthesized Aptamer With a Sticky Bridge
- (2012) Jiehua Zhou et al. MOLECULAR THERAPY
- Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers
- (2012) Kristina W. Thiel et al. NUCLEIC ACIDS RESEARCH
- CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges
- (2012) Filomena de Nigris et al. Recent Patents on Anti-Cancer Drug Discovery
- Increased Vascular Delivery and Efficacy of Chemotherapy after Inhibition of Platelet-Derived Growth Factor-B
- (2011) Beverly L. Falcon et al. AMERICAN JOURNAL OF PATHOLOGY
- Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy
- (2011) Shen Gao et al. International Journal of Nanomedicine
- Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers
- (2011) Fernando Pastor et al. MOLECULAR THERAPY
- Optogenetic manipulation of neural activity in freely moving Caenorhabditis elegans
- (2011) Andrew M Leifer et al. NATURE METHODS
- Molecular aptamers for drug delivery
- (2011) Weihong Tan et al. TRENDS IN BIOTECHNOLOGY
- Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (−) prostate cancers
- (2010) Kyoungin Min et al. BIOMATERIALS
- Effect of 3′-end capping of aptamer with various 2′,4′-bridged nucleotides: Enzymatic post-modification toward a practical use of polyclonal aptamers
- (2010) Yuuya Kasahara et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models
- (2010) Chunhua Lu et al. CANCER BIOLOGY & THERAPY
- A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism
- (2010) E. M. Reyes-Reyes et al. CANCER RESEARCH
- Optogenetic Approaches in Neuroscience
- (2010) André Fiala et al. CURRENT BIOLOGY
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
- (2010) N. Kolishetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Assembly of an Aptamer-Drug Conjugate for Targeted Drug Delivery to Tumor Cells
- (2009) Yu-Fen Huang et al. CHEMBIOCHEM
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
- (2009) Justin P Dassie et al. NATURE BIOTECHNOLOGY
- Assembling OX40 Aptamers on a Molecular Scaffold to Create a Receptor-Activating Aptamer
- (2008) Claudia M. Dollins et al. CHEMISTRY & BIOLOGY
- Cell-Specific Induction of Apoptosis by Rationally Designed Bivalent Aptamer-siRNA Transcripts Silencing Eukaryotic Elongation Factor 2
- (2008) Ulrich Wullner et al. CURRENT CANCER DRUG TARGETS
- Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
- (2008) James O. McNamara et al. JOURNAL OF CLINICAL INVESTIGATION
- Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
- (2008) F. Gu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanotechnology and aptamers: applications in drug delivery
- (2008) Etgar Levy-Nissenbaum et al. TRENDS IN BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search